Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Craig W. Lindsley

Drugs for Allosteric Sites on Receptors

Annual Review of Pharmacology and Toxicology

Toxicology

Pharmacology

2014

English

Competition and Allostery Govern Substrate Selectivity of Cyclooxygenase-2

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2015

English

M1-Positive Allosteric Modulators Lacking Agonist Activity Provide the Optimal Profile for Enhancing Cognition

Neuropsychopharmacology

English

Development of a Series of (1-Benzyl-3-(6-Methoxypyrimidin-3-Yl)-5-(Trifluoromethoxy)-1h-Indol-2-Yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists With in Vivo Utility and Activity Against Γ-Thrombin

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2016

English

In VivoStructure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors

English

Biomimetic Synthesis and Biological Evaluation of Aplidiopsamine A

Organic Letters

Biochemistry

Organic Chemistry

Theoretical Chemistry

Physical

2012

English

Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease

English

cFLIP Critically Modulates Apoptotic Resistance in Epithelial-To-Mesenchymal Transition

Oncotarget

Oncology

2017

English

Recent Progress on the Identification of Metabotropic Glutamate 4 Receptor Ligands and Their Potential Utility as CNS Therapeutics

ACS Chemical Neuroscience

Cognitive Neuroscience

2011

English

Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4)

Journal of Biomolecular Screening

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Craig W. Lindsley

Drugs for Allosteric Sites on Receptors

Competition and Allostery Govern Substrate Selectivity of Cyclooxygenase-2

M1-Positive Allosteric Modulators Lacking Agonist Activity Provide the Optimal Profile for Enhancing Cognition

Development of a Series of (1-Benzyl-3-(6-Methoxypyrimidin-3-Yl)-5-(Trifluoromethoxy)-1h-Indol-2-Yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists With in Vivo Utility and Activity Against Γ-Thrombin

In VivoStructure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors

Biomimetic Synthesis and Biological Evaluation of Aplidiopsamine A

Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease

cFLIP Critically Modulates Apoptotic Resistance in Epithelial-To-Mesenchymal Transition

Recent Progress on the Identification of Metabotropic Glutamate 4 Receptor Ligands and Their Potential Utility as CNS Therapeutics

Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4)